Infertility Clinical Trial
Official title:
A Case Study to Evaluate Adhesion Risk in Fertility Patients' Post Laparoscopic Myomectomy Utilizing Vloc Suture.
Premenopausal Women ages 18-42 will undergo a laparoscopic myomectomy. Prior to the myomectomy, adhesions will be assessed using a modified AFS scoring technique. All investigators will provide usual and customary care to research subjects during the first look laparoscopy. This includes the use of all standard practice anti-adhesive agents and heparinized irrigation fluids.V-Loc 180 suture will be utilized in all patients. All patients will then be evaluated by means of a second look laparoscopy (SLL) 6-12 weeks after the initial surgery and reevaluated via modified American Fertility Society scoring techniques. An independent reviewer will also score adhesions utilize a video recording made from the second look laparoscopic surgery. Patients will be contacted both 1 and 4 weeks post -op and assessed for complications. It is the expectation that patients will show no greater post-operative adhesion formation and a <1% complication rate. Time and ease of suturing will also be evaluated. It is expected that the V-Loc suturing technique will show significantly reduced suturing time, be easier to use, and will be associated with minimal adhesions.
This is a post-market, controlled, single-center study to evaluate V-Loc suture. 10 subjects
will be included in this study. Premenopausal women ages 18-42 will undergo a laparoscopic
myomectomy. Adhesion scoring will be done prior to the myomectomy using a modified American
Fertility Society scoring technique. V-loc 180 suture will be utilized in all patients for
closure of all uterine defects. All patients will then be evaluated by means of a second
look laparoscopy (SLL) 6-12 weeks after the initial surgery and evaluated via modified
American Fertility Society scoring techniques.
An independent reviewer will also score adhesions utilizing video recordings made from the
second look laparoscopic surgery , using the same scoring techniques employed by the PI..
Patients will undergo routine preoperative blood tests in accordance with the Primary
Investigators' usual standard of practice. All patients who meet the inclusion criteria will
be considered. Patients will be consented prior to entry into the operating room. Surgical
time will be measured from start of procedure, start of myomectomy, and start and finish
time of each individual uterine closure. All investigators will provide usual and customary
care to research subjects during the first look laparoscopy. This includes the use of all
standard practice anti-adhesive agents and heparinized irrigation fluids
. Physicians will be surveyed on ease of use and any problems that occur with V-Loc suture.
All patients will be treated with post-operative antibiotics per the Primary Investigator's
usual standard of care. Patients will be contacted both one and 4 weeks post surgery and
evaluated for complications using a phone survey for pain and bowel functioning. The patient
will also have a standard post operative exam with the physician 4-6 weeks post-operatively.
A second look laparoscopy will be performed 6-12 weeks following the initial myomectomy.
Adhesions will be evaluated using a modified American Fertility Society evaluation tool. Any
adhesions seen at the time of SLL will be treated using the physician's preferred method of
adhesiolysis. A recording will be obtained of the second look laparoscopy and will be
reviewed and scored by an independent reviewer as to the level of adhesions seen .
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03607409 -
Role of Inhibin A as Biomarker for Ovarian Response for IVF Treatment
|
||
Recruiting |
NCT02312076 -
GnRHa for Luteal Phase Support in Long GnRHa Protocol Cycles
|
Phase 4 | |
Terminated |
NCT02161861 -
Improvement of IVF Fertilization Rates, by the Cyclic Tripeptide FEE - Prospective Randomized Study
|
N/A | |
Completed |
NCT03287479 -
Comparison of a Semi-automated Closed Vitrification System (Gavi®) With a Manual Open Vitrification Sytem (Cryotop®)
|
N/A | |
Terminated |
NCT03522350 -
Randomized Trial Comparing EmbryoScope With EmbryoScope+.
|
N/A | |
Completed |
NCT04496284 -
Embryo Transfer Outcomes After Vitrification With Slush Nitrogen Compared to Liquid Nitrogen
|
N/A | |
Completed |
NCT03623659 -
pArtiaL zonA pelluciDa Removal by assisteD hatchINg of Blastocysts
|
N/A | |
Completed |
NCT03895099 -
New Ovarian Stimulation With Random Start, Use of Progestin Protocol for Oocyte Donors
|
Phase 3 | |
Active, not recruiting |
NCT04142112 -
Randomized, Standard-Controlled, Study to Evaluate the Ohana IVF Sperm Preparation Kit, SPeRtility IVF Next Generation
|
N/A | |
Completed |
NCT03152643 -
Cumulative Live Birth Rates After Cleavage-stage Versus Blastocyst-stage Embryo Transfer
|
N/A | |
Recruiting |
NCT03683771 -
Assessment of Endometrial Pattern and Sub-endometrial Vascularity in ICSI Outcome
|
||
Recruiting |
NCT03161119 -
Comparing Two Different Embryo Transfer Catheters
|
N/A | |
Completed |
NCT04108039 -
Micronized Progesterone vs Gonadotropin-releasing Hormone (GnRH) Antagonist in Freeze-all IVF Cycles.
|
N/A | |
Completed |
NCT03678818 -
Supplementing Intracytoplasmic Sperm Injection Handling Medium With Latrunculin A (ICSI-LA)
|
N/A | |
Completed |
NCT03678597 -
Supplementing Intracytoplasmic Sperm Injection Handling Medium With Latrunculin B ( ICSI-LB)
|
N/A | |
Completed |
NCT03677492 -
Supplementing Intracytoplasmic Sperm Injection Handling Medium With Cytochalasin D ( ICSI-CD)
|
N/A | |
Completed |
NCT03678558 -
Oocyte Vitrification Aided With Cytochalasin B
|
N/A | |
Completed |
NCT03678584 -
Supplementing Intracytoplasmic Sperm Injection Handling Medium With Chaetoglobosin A ( ICSI-CA)
|
N/A | |
Completed |
NCT03678610 -
Handling Medium for ICSI With Ionomycin and Latrunculin A
|
N/A | |
Completed |
NCT03678571 -
Oocyte Vitrification Aided With Latrunculin A
|
N/A |